Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 05, 2015 2:05 PM ET

Pharmaceuticals

Company Overview of Shilpa Medicare Limited

Company Overview

Shilpa Medicare Limited manufactures and sells bulk drugs in India. It offers active pharmaceutical ingredients, intermediates (APIs), formulations, drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company provides its APIs, intermediates, and formulations in the therapeutic areas of oncology, anti-retroviral, multiple sclerosis, immunosuppressant therapies, etc. Shilpa Medicare Limited also exports its products to the United States, Canada, Australia, and Japan; European countries, such as Germany, Switzerland, the Netherlands, Belgium, Spain, Greece, Cyprus, Italy, the United Kingdom, etc.; South American countries, including Mexico, Brazil, Columbia, etc.; A...

10/80, Rajendra Gunj

1st Floor

Raichur,  584102

India

Founded in 1987

Phone:

91 85 3223 6494

Fax:

91 85 3223 5876

Key Executives for Shilpa Medicare Limited

Shilpa Medicare Limited does not have any Key Executives recorded.

Shilpa Medicare Limited Key Developments

Shilpa Medicare Limited Proposes Dividend for the Financial Year 2014-15

Shilpa Medicare Limited announced that at the SBM held on May 29, 2015, the board of directors recommended a dividend of INR 1.10 per equity share of INR 2 each (that is 55%) for the financial year 2014-15.

Shilpa Medicare Limited Reports Audited Standalone and Consolidated Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2015

Shilpa Medicare Limited reported audited standalone and consolidated earnings results for the fourth quarter and full year ended March 31, 2015. For the quarter, the parent company reported net sales of INR 1,501.032 million, profit from operations before other income, finance costs and exceptional items of INR 336.840 million, profit from ordinary activities before tax of INR 338.619 million and net profit after taxes, minority interest and share of loss of associates of INR 235.423 million or INR 6.14 per diluted share (after extraordinary items not annualized) compared to net sales of INR 1,563.767 million, profit from operations before other income, finance costs and exceptional items of INR 299.628 million, profit from ordinary activities before tax of INR 305.615 million and net profit after taxes, minority interest and share of loss of associates of INR 233.055 million or INR 6.05 per diluted share (after extraordinary items not annualized) reported in the same period last year. For the quarter, the Group reported net sales of INR 1,667.327 million, profit from operations before other income, finance costs and exceptional items of INR 323.673 million, profit from ordinary activities before tax of INR 322.161 million and net profit after taxes, minority interest and share of loss of associates of INR 224.741 million or INR 5.86 per diluted share (after extraordinary items not annualized) compared to net sales of INR 1,674.452 million, profit from operations before other income, finance costs and exceptional items of INR 295.032 million, profit from ordinary activities before tax of INR 311.775 million and net profit after taxes, minority interest and share of loss of associates of INR 247.031 million or INR 6.41 per diluted share (after extraordinary items not annualized) reported in the same period last year. For the year, the parent company reported net sales of INR 5,654.021 million, profit from operations before other income, finance costs and exceptional items of INR 1,174.428 million, profit from ordinary activities before tax of INR 1,190.164 million and net profit after taxes, minority interest and share of loss of associates of INR 841.811 million or INR 21.94 per diluted share (after extraordinary items not annualized) compared to net sales of INR 5,273.681 million, profit from operations before other income, finance costs and exceptional items of INR 966.260 million, profit from ordinary activities before tax of INR 1,020.819 million and net profit after taxes, minority interest and share of loss of associates of INR 808.568 million or INR 20.97 per diluted share (after extraordinary items not annualized) reported in the same period last year. For the year, the Group reported net sales of INR 6,137.991 million, profit from operations before other income, finance costs and exceptional items of INR 1,072.237 million, profit from ordinary activities before tax of INR 1,079.724 million and net profit after taxes, minority interest and share of loss of associates of INR 737.747 million or INR 19.22 per diluted share (after extraordinary items not annualized) compared to net sales of INR 5,713.762 million, profit from operations before other income, finance costs and exceptional items of INR 928.080 million, profit from ordinary activities before tax of INR 983.543 million and net profit after taxes, minority interest and share of loss of associates of INR 756.692 million or INR 19.63 per diluted share (after extraordinary items not annualized) reported in the same period last year.

Shilpa Medicare Limited to Report Fiscal Year 2015 Results on May 29, 2015

Shilpa Medicare Limited announced that they will report fiscal year 2015 results on May 29, 2015

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
January 30, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Shilpa Medicare Limited, please visit www.vbshilpa.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.